share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

SEC ·  Oct 17 04:54

Summary by Moomoo AI

Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on October 15, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Bourla's relationship with the company as Chairman & CEO places him in a position of significant influence, and such transactions are closely monitored by investors for insights into executive confidence in the company's performance.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on October 15, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Bourla's relationship with the company as Chairman & CEO places him in a position of significant influence, and such transactions are closely monitored by investors for insights into executive confidence in the company's performance.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more